Literature DB >> 1378424

Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing.

S R Burrows1, A Suhrbier, R Khanna, D J Moss.   

Abstract

Synthetic peptides are widely used to define the specificity of CD8+ cytotoxic T-lymphocyte (CTL) clones. When many peptides need to be tested by the standard chromium release assay large numbers of a CTL clone are required. Specific synthetic peptide epitopes induce CTL clones to kill each other. This phenomenon can be directly visualized using an inverted microscope and forms the basis for a convenient assay, which can be performed with as few as 100 CTL per peptide and does not require radiolabelled targets.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378424      PMCID: PMC1421752     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  8 in total

1.  The specificity of recognition of a cytotoxic T lymphocyte epitope.

Authors:  S R Burrows; S J Rodda; A Suhrbier; H M Geysen; D J Moss
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

2.  Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes.

Authors:  P R Walden; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.

Authors:  S R Burrows; I S Misko; T B Sculley; C Schmidt; D J Moss
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.

Authors:  C Schmidt; S R Burrows; T B Sculley; D J Moss; I S Misko
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

5.  The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes.

Authors:  B Schick; G Berke
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

6.  Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells.

Authors:  R M Pemberton; D C Wraith; B A Askonas
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

7.  T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism.

Authors:  D J Moss; S R Burrows; G D Baxter; M F Lavin
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

8.  Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.

Authors:  T H Ottenhoff; T Mutis
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

  8 in total
  11 in total

1.  CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy.

Authors:  Kazue Watanabe; Susumu Suzuki; Michi Kamei; Shingo Toji; Takakazu Kawase; Toshitada Takahashi; Kiyotaka Kuzushima; Yoshiki Akatsuka
Journal:  Int J Hematol       Date:  2008-08-05       Impact factor: 2.490

2.  The antigen self-presentation function of the cytotoxic T-cell clone 10BK.1 depends on reciprocal peptide presentation.

Authors:  M S Staege; T Dick; R Ertl; U Jahnel; H Nawrath; H G Rammensee; A B Reske-Kunz
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

3.  A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.

Authors:  S M Morgan; G W Wilkinson; E Floettmann; N Blake; A B Rickinson
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.

Authors:  Georg Lautscham; Tracey Haigh; Sabine Mayrhofer; Graham Taylor; Debbie Croom-Carter; Alison Leese; Stephan Gadola; Vincenzo Cerundolo; Alan Rickinson; Neil Blake
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 5.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

6.  Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions.

Authors:  Jaikumar Duraiswamy; Jacqueline M Burrows; Mandvi Bharadwaj; Scott R Burrows; Leanne Cooper; Nattiya Pimtanothai; Rajiv Khanna
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

7.  Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.

Authors:  N M Steven; N E Annels; A Kumar; A M Leese; M G Kurilla; A B Rickinson
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

8.  Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.

Authors:  N M Steven; A M Leese; N E Annels; S P Lee; A B Rickinson
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

9.  Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.

Authors:  S L Silins; S M Cross; S L Elliott; S J Pye; S R Burrows; J M Burrows; D J Moss; V P Argaet; I S Misko
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

10.  Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

Authors:  V P Argaet; C W Schmidt; S R Burrows; S L Silins; M G Kurilla; D L Doolan; A Suhrbier; D J Moss; E Kieff; T B Sculley; I S Misko
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.